The role of remdesivir in South Africa : preventing COVID-19 deaths through increasing intensive care unit capacity
dc.contributor.author | Nichols, Brooke E. | en_ZA |
dc.contributor.author | Jamieson, Lise | en_ZA |
dc.contributor.author | Zhang, Sabrina R. C. | en_ZA |
dc.contributor.author | Rao, Gabriella A. | en_ZA |
dc.contributor.author | Silal, Sheetal | en_ZA |
dc.contributor.author | Pulliam, Juliet R. C. | en_ZA |
dc.contributor.author | Sanne, Ian | en_ZA |
dc.contributor.author | Meyer-Rath, Gesine | en_ZA |
dc.date.accessioned | 2022-06-07T09:57:22Z | |
dc.date.available | 2022-06-07T09:57:22Z | |
dc.date.issued | 2021-05 | |
dc.description | CITATION: Nichols, B. E. et al. 2020. The Role of Remdesivir in South Africa: Preventing COVID-19 Deaths Through Increasing Intensive Care Unit Capacity. Clinical Infectious Diseases: 72(9), 1642–1644, doi:10.1093/cid/ciaa937 | |
dc.description | The original publication is available at https://academic.oup.com/cid/ | |
dc.description.abstract | Countries such as South Africa have limited intensive care unit (ICU) capacity to handle the expected number of patients with COVID-19 requiring ICU care. Remdesivir can prevent deaths in countries such as South Africa by decreasing the number of days people spend in ICU, therefore freeing up ICU bed capacity. | en_ZA |
dc.description.uri | https://academic.oup.com/cid/article/72/9/1642/5868030?login=true | |
dc.description.version | Publishers version | |
dc.format.extent | 3 pages : illustrations | |
dc.identifier.citation | Nichols, B. E. et al. 2020. The Role of Remdesivir in South Africa: Preventing COVID-19 Deaths Through Increasing Intensive Care Unit Capacity. Clinical Infectious Diseases: 72(9), 1642–1644, doi:10.1093/cid/ciaa937 | |
dc.identifier.issn | 1537-6591 (online) | |
dc.identifier.issn | 1058-4838 (print) | |
dc.identifier.other | doi:10.1093/cid/ciaa937 | |
dc.identifier.uri | http://hdl.handle.net/10019.1/125331 | |
dc.language.iso | en_ZA | en_ZA |
dc.publisher | Oxford University Press | |
dc.rights.holder | Authors retain copyright | |
dc.subject | COVID-19 (Disease) – Treatment | en_ZA |
dc.subject | Antiviral agents | en_ZA |
dc.subject | Drugs -- Physiological effect | en_ZA |
dc.title | The role of remdesivir in South Africa : preventing COVID-19 deaths through increasing intensive care unit capacity | en_ZA |
dc.type | Article | en_ZA |